PRQR logo

ProQR Therapeutics NV (PRQR) Depreciation And Amortization

Annual D&A

$2.72 M
+$62.00 K+2.33%

31 December 2023

1-Year Change

+2.33%
PRQR annual depreciation & amortization is up +2.33% year-on-year

3-Year Change

+1.16%
PRQR annual depreciation & amortization is up +1.16% over the past 3 years

All-time High

$2.76 M
PRQR annual depreciation & amortization is currently -1.27% below its historical high of $2.76 million

Sector Rank

53.9%
PRQR annual depreciation & amortization is higher than 53.9% of companies in Healthcare sector
Annual Total Expenses$44.72 M
PRQR annual total expenses is $44.72 million
Annual Operating Expenses$44.72 M
PRQR annual total operating expenses is $44.72 million
Annual Revenue$7.05 M
PRQR annual revenue is $7.05 million
Annual Net Income-$30.44 M
PRQR annual net profit is -$30.44 million

PRQR Depreciation And Amortization Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly D&A

$789.00 K
+$30.00 K+3.95%

01 September 2024

1-Year Change

+13.18%
PRQR quarterly depreciation & amortization is up +13.18% year-on-year

3-Year Change

+29.51%
PRQR quarterly depreciation & amortization is up +29.51% over the past 3 years

All-time High

$872.60 K
PRQR quarterly depreciation & amortization is currently -9.58% below its historical high of $872.60 thousand

Sector Rank

55%
PRQR quarterly depreciation & amortization is higher than 55% of companies in Healthcare sector
Quarterly Total Expenses$13.96 M
PRQR quarterly total expenses is $13.96 million
Quarterly Operating Expenses$13.96 M
PRQR quarterly total operating expenses is $13.96 million
Quarterly Revenue$4.23 M
PRQR quarterly revenue is $4.23 million
Quarterly Net Income-$8.92 M
PRQR quarterly net profit is -$8.92 million

PRQR Quarterly D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM D&A

$3.08 M
+$91.90 K+3.08%

01 September 2024

1-Year Change

+9.22%
PRQR TTM depreciation & amortization is up +9.22% year-on-year

3-Year Change

+10.11%
PRQR TTM depreciation & amortization is up +10.11% over the past 3 years

All-time High

$3.08 M
PRQR TTM depreciation & amortization is currently at an all-time high

Sector Rank

54.15%
PRQR TTM depreciation & amortization is higher than 54.15% of companies in Healthcare sector
Annual Total Expenses$44.72 M
PRQR annual total expenses is $44.72 million
Annual Operating Expenses$44.72 M
PRQR annual total operating expenses is $44.72 million
TTM Revenue$19.39 M
PRQR TTM revenue is $19.39 million
TTM Net Income-$26.04 M
PRQR TTM net profit is -$26.04 million

PRQR TTM D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PRQR Depreciation And Amortization Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+2.3%+13.2%+9.2%
3 y3 years+1.2%+29.5%+10.1%
5 y5 years+132.3%+43.3%+50.5%

PRQR Depreciation And Amortization High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-1.3%+2.3%-9.6%+43.6%at high+25.7%
5 y5 years-1.3%+132.3%-9.6%+43.6%at high+50.5%
alltimeall time-1.3%+8428.5%-9.6%+3286.3%at high>+9999.0%

ProQR Therapeutics NV Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sept 2024
-
$789.00 K(+4.0%)
$3.08 M(+3.1%)
June 2024
-
$759.00 K(+1.1%)
$2.98 M(+3.6%)
Mar 2024
-
$750.60 K(-3.4%)
$2.88 M(+5.9%)
Dec 2023
$2.72 M(+2.3%)
$777.10 K(+11.5%)
$2.72 M(-3.4%)
Sept 2023
-
$697.10 K(+6.2%)
$2.82 M(+5.5%)
June 2023
-
$656.70 K(+11.4%)
$2.67 M(+2.3%)
Mar 2023
-
$589.60 K(-32.4%)
$2.61 M(-1.9%)
Dec 2022
$2.66 M(-3.5%)
$872.60 K(+58.8%)
$2.66 M(+8.7%)
Sept 2022
-
$549.40 K(-8.0%)
$2.45 M(-2.4%)
June 2022
-
$597.10 K(-6.6%)
$2.51 M(-4.9%)
Mar 2022
-
$639.60 K(-3.1%)
$2.63 M(-4.4%)
Dec 2021
$2.76 M(+2.5%)
$660.40 K(+8.4%)
$2.76 M(-1.3%)
Sept 2021
-
$609.20 K(-16.0%)
$2.79 M(-7.4%)
June 2021
-
$725.60 K(-4.6%)
$3.02 M(+5.0%)
Mar 2021
-
$760.40 K(+8.9%)
$2.87 M(+6.9%)
Dec 2020
$2.69 M(+17.1%)
$698.00 K(-16.2%)
$2.69 M(+4.5%)
Sept 2020
-
$832.90 K(+43.0%)
$2.57 M(+12.3%)
June 2020
-
$582.50 K(+1.1%)
$2.29 M(+0.4%)
Mar 2020
-
$576.00 K(-0.9%)
$2.28 M(-0.7%)
Dec 2019
$2.30 M
$581.50 K(+5.6%)
$2.30 M(+12.4%)
Sept 2019
-
$550.70 K(-3.9%)
$2.04 M(+16.2%)
June 2019
-
$573.10 K(-3.2%)
$1.76 M(+19.8%)
DateAnnualQuarterlyTTM
Mar 2019
-
$591.80 K(+80.2%)
$1.47 M(+25.4%)
Dec 2018
$1.17 M(-2.9%)
$328.40 K(+23.3%)
$1.17 M(+6.5%)
Sept 2018
-
$266.30 K(-5.5%)
$1.10 M(-7.4%)
June 2018
-
$281.90 K(-4.4%)
$1.19 M(-2.2%)
Mar 2018
-
$294.80 K(+14.5%)
$1.22 M(+0.8%)
Dec 2017
$1.21 M(-12.5%)
$257.40 K(-27.4%)
$1.21 M(-2.3%)
Sept 2017
-
$354.60 K(+14.9%)
$1.24 M(+4.0%)
June 2017
-
$308.60 K(+8.1%)
$1.19 M(-8.3%)
Mar 2017
-
$285.50 K(-0.3%)
$1.29 M(-6.0%)
Dec 2016
$1.38 M(+158.7%)
$286.40 K(-6.9%)
$1.38 M(+10.4%)
Sept 2016
-
$307.50 K(-26.0%)
$1.25 M(+15.3%)
June 2016
-
$415.60 K(+12.8%)
$1.08 M(+36.3%)
Mar 2016
-
$368.50 K(+134.7%)
$794.00 K(+49.1%)
Dec 2015
$532.70 K(+217.8%)
$157.00 K(+11.0%)
$532.70 K(+16.5%)
Sept 2015
-
$141.40 K(+11.3%)
$457.10 K(+31.2%)
June 2015
-
$127.10 K(+18.6%)
$348.30 K(+38.5%)
Mar 2015
-
$107.20 K(+31.7%)
$251.40 K(+50.1%)
Dec 2014
$167.60 K(+425.4%)
$81.40 K(+149.7%)
$167.50 K(+94.5%)
Sept 2014
-
$32.60 K(+7.9%)
$86.10 K(+60.9%)
June 2014
-
$30.20 K(+29.6%)
$53.50 K(+129.6%)
Mar 2014
-
$23.30 K
$23.30 K
Dec 2013
$31.90 K
-
-

FAQ

  • What is ProQR Therapeutics NV annual depreciation & amortization?
  • What is the all time high annual D&A for ProQR Therapeutics NV?
  • What is ProQR Therapeutics NV annual D&A year-on-year change?
  • What is ProQR Therapeutics NV quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for ProQR Therapeutics NV?
  • What is ProQR Therapeutics NV quarterly D&A year-on-year change?
  • What is ProQR Therapeutics NV TTM depreciation & amortization?
  • What is the all time high TTM D&A for ProQR Therapeutics NV?
  • What is ProQR Therapeutics NV TTM D&A year-on-year change?

What is ProQR Therapeutics NV annual depreciation & amortization?

The current annual D&A of PRQR is $2.72 M

What is the all time high annual D&A for ProQR Therapeutics NV?

ProQR Therapeutics NV all-time high annual depreciation & amortization is $2.76 M

What is ProQR Therapeutics NV annual D&A year-on-year change?

Over the past year, PRQR annual depreciation & amortization has changed by +$62.00 K (+2.33%)

What is ProQR Therapeutics NV quarterly depreciation & amortization?

The current quarterly D&A of PRQR is $789.00 K

What is the all time high quarterly D&A for ProQR Therapeutics NV?

ProQR Therapeutics NV all-time high quarterly depreciation & amortization is $872.60 K

What is ProQR Therapeutics NV quarterly D&A year-on-year change?

Over the past year, PRQR quarterly depreciation & amortization has changed by +$91.90 K (+13.18%)

What is ProQR Therapeutics NV TTM depreciation & amortization?

The current TTM D&A of PRQR is $3.08 M

What is the all time high TTM D&A for ProQR Therapeutics NV?

ProQR Therapeutics NV all-time high TTM depreciation & amortization is $3.08 M

What is ProQR Therapeutics NV TTM D&A year-on-year change?

Over the past year, PRQR TTM depreciation & amortization has changed by +$259.70 K (+9.22%)